Royal Bank of Canada’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-22
| Closed | – | – | 7363 |
|
|
2023
Q2 | $0 | Buy |
22
+2
| +10% | – | ﹤0.01% | 7442 |
|
|
2023
Q1 | $0 | Hold |
20
| – | – | ﹤0.01% | 7284 |
|
|
2022
Q4 | $0 | Hold |
20
| – | – | ﹤0.01% | 7621 |
|
|
2022
Q3 | $0 | Hold |
20
| – | – | ﹤0.01% | 7683 |
|
|
2022
Q2 | $0 | Hold |
20
| – | – | ﹤0.01% | 7649 |
|
|
2022
Q1 | $0 | Hold |
20
| – | – | ﹤0.01% | 7666 |
|
|
2021
Q4 | $0 | Hold |
20
| – | – | ﹤0.01% | 7644 |
|
|
2021
Q3 | $1K | Hold |
20
| – | – | ﹤0.01% | 7052 |
|
|
2021
Q2 | $1K | Hold |
20
| – | – | ﹤0.01% | 6917 |
|
|
2021
Q1 | $1K | Hold |
20
| – | – | ﹤0.01% | 6867 |
|
|
2020
Q4 | $1K | Sell |
20
-2
| -9% | -$100 | ﹤0.01% | 6464 |
|
|
2020
Q3 | $3K | Hold |
22
| – | – | ﹤0.01% | 5784 |
|
|
2020
Q2 | $3K | Buy |
22
+8
| +57% | +$1.09K | ﹤0.01% | 5766 |
|
|
2020
Q1 | $2K | Buy |
14
+4
| +40% | +$571 | ﹤0.01% | 5871 |
|
|
2019
Q4 | $4K | Hold |
10
| – | – | ﹤0.01% | 5838 |
|
|
2019
Q3 | $5K | Buy |
10
+4
| +67% | +$2K | ﹤0.01% | 5424 |
|
|
2019
Q2 | $3K | Sell |
6
-2
| -25% | -$1K | ﹤0.01% | 5578 |
|
|
2019
Q1 | $5K | Hold |
8
| – | – | ﹤0.01% | 5338 |
|
|
2018
Q4 | $3K | Sell |
8
-9
| -53% | -$3.38K | ﹤0.01% | 5502 |
|
|
2018
Q3 | $11K | Sell |
17
-37
| -69% | -$23.9K | ﹤0.01% | 5353 |
|
|
2018
Q2 | $47K | Sell |
54
-42
| -44% | -$36.6K | ﹤0.01% | 4607 |
|
|
2018
Q1 | $121K | Sell |
96
-36
| -27% | -$45.4K | ﹤0.01% | 3995 |
|
|
2017
Q4 | $198K | Sell |
132
-117
| -47% | -$176K | ﹤0.01% | 3728 |
|
|
2017
Q3 | $509K | Buy |
249
+38
| +18% | +$77.7K | ﹤0.01% | 3143 |
|
|
2017
Q2 | $553K | Buy |
211
+34
| +19% | +$89.1K | ﹤0.01% | 2977 |
|
|
2017
Q1 | $530K | Buy |
177
+171
| +2,850% | +$512K | ﹤0.01% | 3029 |
|
|
2016
Q4 | $10K | Buy |
+6
| New | +$10K | ﹤0.01% | 5337 |
|